Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 November 2008

Arch. Dis. Child. Fetal Neonatal Ed.. Published Online First: 19 February 2008. doi:10.1136/adc.2007.133140
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

Original articles

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death of severe intraventricular haemorrhage

Afif Faisal EL-Khuffash 1*, Declan Barry 1, Kevin Walsh 2, Peter Graham Davis 3 and Eleanor J Molloy 4

1 National Maternity Hospital, Republic of Ireland
2 Our Ladys Hospital for Sick Children, Republic of Ireland
3 Royal Women's Hospital, Melbourne, Australia
4 National Maternity hospital, Republic of Ireland

* To whom correspondence should be addressed. E-mail: afif_faisal{at}hotmail.com.

Accepted 5 February 2008


Abstract

Background: A patent ductus arteriosus (PDA) in preterm infants is associated with increased risk of intraventricular haemorrhage (IVH), and death. Cardiac troponin T (cTnT) and Pro-B-type Natriuretic Peptide (NTpBNP) are markers of cardiac function and can predict poor outcome in adults.

Aims: To determine whether echocardiography and cTnT/NTpBNP levels at 48 hours predict death before discharge or severe IVH in preterm infants with a PDA.

Methods: Infants born < 32 weeks gestation or < 1500g underwent echocardiographic and cTnT/NTpBNP measurements at 12 and 48 hours of life. Infants were divided according to their status at discharge: a closed PDA at 48 hours, infants with a PDA at 48 hours and IVH III/IV and/or death, and infants with a PDA at 48 hours without IVH III/IV or death.

Results: Eighty infants with a median gestation of 28 weeks [IQR:26.1–29.5] and birth weight 1.06 kg [0.8 –1.21] were included. At 48 hours, infants with a PDA and IVH III/IV and/or death had significantly higher median NTpBNP/cTnT levels compared to infants with a PDA without IVH III/IV and/or death and those with spontaneous PDA closure (NTpBNP: 9282, 5121, and 740 pmol/L respectively, p=0.008, and cTnT: 0.66, 0.25, and 0.13 µg/L respectively, p=0.027). There were no differences in echocardiographic parameters of PDA size, LA:Ao ratio, left and right ventricular outputs between the PDA groups.

Conclusions: NTpBNP and cTnT in conjunction with echocardiography may provide a basis for trials of targeted medical treatment in infants with a PDA.

Keywords: NTpBNP, cTnT, patent ductus arteriosus, preterm infant


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2008 93: F399. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs